导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -3.27% | 659/1050 |
| 近一周 | -1.46% | 704/1103 |
| 近一月 | -3.57% | 273/1102 |
| 近一季 | -8.52% | 569/1094 |
| 近半年 | -10.86% | 825/1074 |
| 近一年 | -7.42% | 696/1020 |
| 近两年 | 33.68% | 648/926 |
| 近三年 | 14.05% | 561/834 |
| 成立以来 | 162.18% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
4.17% 189/1070 |
2.67% 650/1101 |
- - |
- - |
| 2025 | 31.29% 454/1065 |
8.24% 215/1014 |
6.03% 238/1038 |
21.37% 567/1050 |
-5.74% 730/1065 |
| 2024 | -0.18% 587/1011 |
0.82% 275/960 |
6.87% 52/983 |
1.69% 944/991 |
-8.90% 871/1011 |
| 2023 | -15.73% 553/952 |
3.81% 387/880 |
-8.01% 693/895 |
-4.09% 247/915 |
-8.00% 757/952 |
| 2022 | -23.74% 458/867 |
-23.17% 675/773 |
6.63% 427/806 |
-8.06% 146/845 |
1.25% 370/867 |
| 2021 | -5.63% 424/740 |
-3.88% 298/580 |
9.60% 368/659 |
-11.09% 538/704 |
0.76% 406/740 |
| 2020 | 67.44% 153/554 |
-8.47% 364/419 |
30.55% 122/466 |
13.67% 167/517 |
23.27% 88/554 |
| 2019 | 44.07% 190/410 |
26.89% 554/1146 |
-1.08% 446/1228 |
3.76% 226/390 |
10.62% 146/410 |
| 2018 | -17.91% 49/349 |
- - |
- - |
-2.92% 366/1000 |
-14.60% 859/1080 |
| 2017 | 49.39% 5/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 银华沪港深增长股票A VS. 东吴新产业精选股票A(580008) |